ERBB2 and breast carcinoma: In a rat orthotopic U87MG intracranial glioblastoma xenograft preclinical model, abemaciclib crossed the BBB and increased survival [18], indicating that abemaciclib may have activity in brain metastases arising from HR+ HER2− advanced breast cancer.